Vyvanse—a medication approved in 2007 for attention-deficit/hyperactivity disorder (ADHD)—is the fir...

Yesterday, the Food and Drug Administration (FDA) released a statement concerning the therapeutic be...

A large proportion of individuals with ADHD fail to seek treatment for the disorder, and among those...

A comparison of young people diagnosed with attention-deficit/hyperactivity disorder (ADHD) using DS...

Very young children and those in foster care who are enrolled in Maryland’s Medicaid program are mor...

A collaborative care model based in pediatric practices showed significant advantages over enhanced ...